These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Mechanistic insight into E22Q-mutation-induced antiparallel-to-parallel β-sheet transition of Aβ16-22 fibrils: an all-atom simulation study. Li X, Lei J, Qi R, Xie L, Wei G. Phys Chem Chem Phys; 2019 Jul 17; 21(28):15686-15694. PubMed ID: 31271401 [Abstract] [Full Text] [Related]
8. Deciphering the Role of ATP on PHF6 Aggregation. Pal S, Roy R, Paul S. J Phys Chem B; 2022 Jul 07; 126(26):4761-4775. PubMed ID: 35759245 [Abstract] [Full Text] [Related]
12. Heparin remodels the microtubule-binding repeat R3 of Tau protein towards fibril-prone conformations. Dong X, Qi R, Qiao Q, Li X, Li F, Wan J, Zhang Q, Wei G. Phys Chem Chem Phys; 2021 Sep 22; 23(36):20406-20418. PubMed ID: 34494046 [Abstract] [Full Text] [Related]
13. Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer's disease-like symptoms in animal model. Viswanathan GK, Shwartz D, Losev Y, Arad E, Shemesh C, Pichinuk E, Engel H, Raveh A, Jelinek R, Cooper I, Gosselet F, Gazit E, Segal D. Cell Mol Life Sci; 2020 Jul 22; 77(14):2795-2813. PubMed ID: 31562564 [Abstract] [Full Text] [Related]
14. ATP Controls the Aggregation of Aβ16-22 Peptides. Pal S, Paul S. J Phys Chem B; 2020 Jan 09; 124(1):210-223. PubMed ID: 31830415 [Abstract] [Full Text] [Related]
15. Integrating in vitro and in silico approaches to evaluate the "dual functionality" of palmatine chloride in inhibiting and disassembling Tau-derived VQIVYK peptide fibrils. Haj E, Losev Y, Guru KrishnaKumar V, Pichinuk E, Engel H, Raveh A, Gazit E, Segal D. Biochim Biophys Acta Gen Subj; 2018 Jul 09; 1862(7):1565-1575. PubMed ID: 29634991 [Abstract] [Full Text] [Related]
16. The Effects of Different Glycosaminoglycans on the Structure and Aggregation of the Amyloid-β (16-22) Peptide. Samantray S, Strodel B. J Phys Chem B; 2021 Jun 03; 125(21):5511-5525. PubMed ID: 34027669 [Abstract] [Full Text] [Related]
18. Terminal Capping of an Amyloidogenic Tau Fragment Modulates Its Fibrillation Propensity. Arya S, Ganguly P, Arsiccio A, Claud SL, Trapp B, Schonfeld GE, Liu X, Lazar Cantrell K, Shea JE, Bowers MT. J Phys Chem B; 2020 Oct 08; 124(40):8772-8783. PubMed ID: 32816481 [Abstract] [Full Text] [Related]
19. Molecular dynamics simulations reveal the disruption mechanism of a 2,4-thiazolidinedione derivative C30 against tau hexapeptide (PHF6) oligomer. Liu H, Zhong H, Liu H, Yao X. Proteins; 2022 Jan 08; 90(1):142-154. PubMed ID: 34331342 [Abstract] [Full Text] [Related]
20. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study. Sun Y, Qian Z, Wei G. Phys Chem Chem Phys; 2016 May 14; 18(18):12582-91. PubMed ID: 27091578 [Abstract] [Full Text] [Related] Page: [Next] [New Search]